Table 1. Characterization of the sample.
| Characteristics | Sample (n = 30) | Men (n = 15) | Women (n = 15) | p |
|---|---|---|---|---|
| Age (years) | 71.0±7.9 | 71 (67–77) | 66 (62–77) | 0.18 |
| Weight (kg) | 71.8±14.4 | 78.5±12.7 | 65.1±13.1 | 0.008* |
| Height (m) | 1.7±0.1 | 1.7±0.1 | 1.6±0.1 | <0.001* |
| BMI (kg/m2) | 26.2±4.8 | 25.1 (23.2–28.2) | 25.7 (20.5–28.9) | 0.93 |
| Evaluation day (day) | 5 (4–6) | 5 (3–8) | 5 (4–6) | 0.73 |
| MMSE (points) | 29 (27–29) | 29 (28–29) | 29 (27–29) | 0.50 |
| CCI (points) | 1 (0–3) | 1 (0–3) | 1 (0–3) | 0.90 |
| Total muscle mass (kg) | 47.0±9.4 | 53.6 (50.1–57.3) | 41.4 (34.9–44.0) | <0.001* |
| Appendicular muscle mass (kg) | 20.2±4.2 | 23.0 (20.9–24.9) | 17.6 (14.6–19.6) | <0.001* |
| Body fat tissue (%) | 30.5±7.8 | 27.1±6.8 | 34.0±7.4 | 0.01* |
| HGS (kgf) | 26.7±9.0 | 33.7±6.2 | 19.6±4.7 | <0.001* |
| 6GST (m/s) | 1.4±0.4 | 1.5±0.34 | 1.3±0.4 | 0.07 |
| 6MST (cycles) | 211.3±98.7 | 242.7±99.7 | 179.9±90.1 | 0.08 |
| Comorbidities | ||||
| Cancer (%) | 13 (43.3) | 6 (40.0) | 7 (46.7) | - |
| COPD (%) | 4 (13.3) | 2 (13.3) | 2 (13.3) | - |
| Hypertension (%) | 14 (46.7) | 6 (40.0) | 8 (53.3) | - |
| Diabetes Mellitus (%) | 9 (30.0) | 7 (46.7) | 2 (13.3) | - |
| Dyslipidemia (%) | 9 (30.0) | 7 (46.7) | 2 (13.3) | - |
| Reason for hospitalization | ||||
| Clinical | 20 (66.7) | 9 (60.0) | 11 (73.3) | - |
| Surgical | 10 (33.3) | 6 (40.0) | 4 (26.7) | - |
kg: kilograms; m: meters; BMI: body mass index; MMSE: mini mental state examination; CCI: Charlson comorbidity index; HGS: handgrip strength; kgf: kilogram force; 6GST: six-meter gait speed test; s: seconds; 6MST: six-minute stepper test; COPD: chronic obstructive pulmonary disease;
*significant difference between men and women.